 | • レポートコード：MRC2-11QY11894 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエクソソームのグローバル市場について調査・分析したレポートです。種類別（ノンコーディングRNA、脂質、mRNA、DNA断片、タンパク質/ペプチド）市場規模、用途別（がん、感染症、神経変性疾患、循環器疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エクソソームの競争状況、市場シェア ・世界のエクソソーム市場：種類別市場規模 2015年-2020年（ノンコーディングRNA、脂質、mRNA、DNA断片、タンパク質/ペプチド） ・世界のエクソソーム市場：種類別市場規模予測 2021年-2026年（ノンコーディングRNA、脂質、mRNA、DNA断片、タンパク質/ペプチド） ・世界のエクソソーム市場：用途別市場規模 2015年-2020年（がん、感染症、神経変性疾患、循環器疾患） ・世界のエクソソーム市場：用途別市場規模予測 2021年-2026年（がん、感染症、神経変性疾患、循環器疾患） ・北米のエクソソーム市場分析：米国、カナダ ・ヨーロッパのエクソソーム市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエクソソーム市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエクソソーム市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエクソソーム市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Fujifilm、Thermo Fisher Scientific、Danaher、Illumina、Qiagen、Takara Bio、Malvern Instruments、Miltenyi Biotec、MBL International、Lonza ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures
Exponential growth in revenue is anticipated over the coming decade due to granular and bottom-up efforts made by researchers in the field. Rising number of research grants and projects by various research organizations will also contribute toward market growth.
Market Analysis and Insights: Global Exosomes Market
The global Exosomes market size is projected to reach US$ 302 million by 2026, from US$ 270.8 million in 2020, at a CAGR of 10.7%% during 2021-2026.
Global Exosomes Scope and Market Size
Exosomes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Exosomes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Fujifilm
Thermo Fisher Scientific
Danaher
Illumina
Qiagen
Takara Bio
Malvern Instruments
Miltenyi Biotec
MBL International
Lonza
Market segment by Type, the product can be split into
Non-coding RNAs
Lipids
mRNA
DNA fragments
Proteins /peptides
Market segment by Application, split into
Cancer
Infectious diseases
Neurodegenerative diseases
Cardiovascular diseases
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Exosomes Revenue
1.4 Market by Type
1.4.1 Global Exosomes Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Non-coding RNAs
1.4.3 Lipids
1.4.4 mRNA
1.4.5 DNA fragments
1.4.6 Proteins /peptides
1.5 Market by Application
1.5.1 Global Exosomes Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Infectious diseases
1.5.4 Neurodegenerative diseases
1.5.5 Cardiovascular diseases
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Exosomes Market Perspective (2015-2026)
2.2 Global Exosomes Growth Trends by Regions
2.2.1 Exosomes Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Exosomes Historic Market Share by Regions (2015-2020)
2.2.3 Exosomes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Exosomes Market Growth Strategy
2.3.6 Primary Interviews with Key Exosomes Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Exosomes Players by Market Size
3.1.1 Global Top Exosomes Players by Revenue (2015-2020)
3.1.2 Global Exosomes Revenue Market Share by Players (2015-2020)
3.1.3 Global Exosomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Exosomes Market Concentration Ratio
3.2.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2019
3.3 Exosomes Key Players Head office and Area Served
3.4 Key Players Exosomes Product Solution and Service
3.5 Date of Enter into Exosomes Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Exosomes Historic Market Size by Type (2015-2020)
4.2 Global Exosomes Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Exosomes Market Size by Application (2015-2020)
5.2 Global Exosomes Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Exosomes Market Size (2015-2020)
6.2 Exosomes Key Players in North America (2019-2020)
6.3 North America Exosomes Market Size by Type (2015-2020)
6.4 North America Exosomes Market Size by Application (2015-2020)
7 Europe
7.1 Europe Exosomes Market Size (2015-2020)
7.2 Exosomes Key Players in Europe (2019-2020)
7.3 Europe Exosomes Market Size by Type (2015-2020)
7.4 Europe Exosomes Market Size by Application (2015-2020)
8 China
8.1 China Exosomes Market Size (2015-2020)
8.2 Exosomes Key Players in China (2019-2020)
8.3 China Exosomes Market Size by Type (2015-2020)
8.4 China Exosomes Market Size by Application (2015-2020)
9 Japan
9.1 Japan Exosomes Market Size (2015-2020)
9.2 Exosomes Key Players in Japan (2019-2020)
9.3 Japan Exosomes Market Size by Type (2015-2020)
9.4 Japan Exosomes Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Exosomes Market Size (2015-2020)
10.2 Exosomes Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Exosomes Market Size by Type (2015-2020)
10.4 Southeast Asia Exosomes Market Size by Application (2015-2020)
11 India
11.1 India Exosomes Market Size (2015-2020)
11.2 Exosomes Key Players in India (2019-2020)
11.3 India Exosomes Market Size by Type (2015-2020)
11.4 India Exosomes Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Exosomes Market Size (2015-2020)
12.2 Exosomes Key Players in Central & South America (2019-2020)
12.3 Central & South America Exosomes Market Size by Type (2015-2020)
12.4 Central & South America Exosomes Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Fujifilm
13.1.1 Fujifilm Company Details
13.1.2 Fujifilm Business Overview
13.1.3 Fujifilm Exosomes Introduction
13.1.4 Fujifilm Revenue in Exosomes Business (2015-2020))
13.1.5 Fujifilm Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Exosomes Introduction
13.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Danaher
13.3.1 Danaher Company Details
13.3.2 Danaher Business Overview
13.3.3 Danaher Exosomes Introduction
13.3.4 Danaher Revenue in Exosomes Business (2015-2020)
13.3.5 Danaher Recent Development
13.4 Illumina
13.4.1 Illumina Company Details
13.4.2 Illumina Business Overview
13.4.3 Illumina Exosomes Introduction
13.4.4 Illumina Revenue in Exosomes Business (2015-2020)
13.4.5 Illumina Recent Development
13.5 Qiagen
13.5.1 Qiagen Company Details
13.5.2 Qiagen Business Overview
13.5.3 Qiagen Exosomes Introduction
13.5.4 Qiagen Revenue in Exosomes Business (2015-2020)
13.5.5 Qiagen Recent Development
13.6 Takara Bio
13.6.1 Takara Bio Company Details
13.6.2 Takara Bio Business Overview
13.6.3 Takara Bio Exosomes Introduction
13.6.4 Takara Bio Revenue in Exosomes Business (2015-2020)
13.6.5 Takara Bio Recent Development
13.7 Malvern Instruments
13.7.1 Malvern Instruments Company Details
13.7.2 Malvern Instruments Business Overview
13.7.3 Malvern Instruments Exosomes Introduction
13.7.4 Malvern Instruments Revenue in Exosomes Business (2015-2020)
13.7.5 Malvern Instruments Recent Development
13.8 Miltenyi Biotec
13.8.1 Miltenyi Biotec Company Details
13.8.2 Miltenyi Biotec Business Overview
13.8.3 Miltenyi Biotec Exosomes Introduction
13.8.4 Miltenyi Biotec Revenue in Exosomes Business (2015-2020)
13.8.5 Miltenyi Biotec Recent Development
13.9 MBL International
13.9.1 MBL International Company Details
13.9.2 MBL International Business Overview
13.9.3 MBL International Exosomes Introduction
13.9.4 MBL International Revenue in Exosomes Business (2015-2020)
13.9.5 MBL International Recent Development
13.10 Lonza
13.10.1 Lonza Company Details
13.10.2 Lonza Business Overview
13.10.3 Lonza Exosomes Introduction
13.10.4 Lonza Revenue in Exosomes Business (2015-2020)
13.10.5 Lonza Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Exosomes Key Market Segments
Table 2. Key Players Covered: Ranking by Exosomes Revenue
Table 3. Ranking of Global Top Exosomes Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Exosomes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-coding RNAs
Table 6. Key Players of Lipids
Table 7. Key Players of mRNA
Table 8. Key Players of DNA fragments
Table 9. Key Players of Proteins /peptides
Table 10. Global Exosomes Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Exosomes Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Exosomes Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Exosomes Market Share by Regions (2015-2020)
Table 14. Global Exosomes Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Exosomes Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Exosomes Market Growth Strategy
Table 20. Main Points Interviewed from Key Exosomes Players
Table 21. Global Exosomes Revenue by Players (2015-2020) (Million US$)
Table 22. Global Exosomes Market Share by Players (2015-2020)
Table 23. Global Top Exosomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosomes as of 2019)
Table 24. Global Exosomes by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Exosomes Product Solution and Service
Table 27. Date of Enter into Exosomes Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Exosomes Market Size by Type (2015-2020) (Million US$)
Table 30. Global Exosomes Market Size Share by Type (2015-2020)
Table 31. Global Exosomes Revenue Market Share by Type (2021-2026)
Table 32. Global Exosomes Market Size Share by Application (2015-2020)
Table 33. Global Exosomes Market Size by Application (2015-2020) (Million US$)
Table 34. Global Exosomes Market Size Share by Application (2021-2026)
Table 35. North America Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Exosomes Market Share (2019-2020)
Table 37. North America Exosomes Market Size by Type (2015-2020) (Million US$)
Table 38. North America Exosomes Market Share by Type (2015-2020)
Table 39. North America Exosomes Market Size by Application (2015-2020) (Million US$)
Table 40. North America Exosomes Market Share by Application (2015-2020)
Table 41. Europe Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Exosomes Market Share (2019-2020)
Table 43. Europe Exosomes Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Exosomes Market Share by Type (2015-2020)
Table 45. Europe Exosomes Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Exosomes Market Share by Application (2015-2020)
Table 47. China Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 48. China Key Players Exosomes Market Share (2019-2020)
Table 49. China Exosomes Market Size by Type (2015-2020) (Million US$)
Table 50. China Exosomes Market Share by Type (2015-2020)
Table 51. China Exosomes Market Size by Application (2015-2020) (Million US$)
Table 52. China Exosomes Market Share by Application (2015-2020)
Table 53. Japan Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Exosomes Market Share (2019-2020)
Table 55. Japan Exosomes Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Exosomes Market Share by Type (2015-2020)
Table 57. Japan Exosomes Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Exosomes Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Exosomes Market Share (2019-2020)
Table 61. Southeast Asia Exosomes Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Exosomes Market Share by Type (2015-2020)
Table 63. Southeast Asia Exosomes Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Exosomes Market Share by Application (2015-2020)
Table 65. India Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 66. India Key Players Exosomes Market Share (2019-2020)
Table 67. India Exosomes Market Size by Type (2015-2020) (Million US$)
Table 68. India Exosomes Market Share by Type (2015-2020)
Table 69. India Exosomes Market Size by Application (2015-2020) (Million US$)
Table 70. India Exosomes Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Exosomes Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Exosomes Market Share (2019-2020)
Table 73. Central & South America Exosomes Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Exosomes Market Share by Type (2015-2020)
Table 75. Central & South America Exosomes Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Exosomes Market Share by Application (2015-2020)
Table 77. Fujifilm Company Details
Table 78. Fujifilm Business Overview
Table 79. Fujifilm Product
Table 80. Fujifilm Revenue in Exosomes Business (2015-2020) (Million US$)
Table 81. Fujifilm Recent Development
Table 82. Thermo Fisher Scientific Company Details
Table 83. Thermo Fisher Scientific Business Overview
Table 84. Thermo Fisher Scientific Product
Table 85. Thermo Fisher Scientific Revenue in Exosomes Business (2015-2020) (Million US$)
Table 86. Thermo Fisher Scientific Recent Development
Table 87. Danaher Company Details
Table 88. Danaher Business Overview
Table 89. Danaher Product
Table 90. Danaher Revenue in Exosomes Business (2015-2020) (Million US$)
Table 91. Danaher Recent Development
Table 92. Illumina Company Details
Table 93. Illumina Business Overview
Table 94. Illumina Product
Table 95. Illumina Revenue in Exosomes Business (2015-2020) (Million US$)
Table 96. Illumina Recent Development
Table 97. Qiagen Company Details
Table 98. Qiagen Business Overview
Table 99. Qiagen Product
Table 100. Qiagen Revenue in Exosomes Business (2015-2020) (Million US$)
Table 101. Qiagen Recent Development
Table 102. Takara Bio Company Details
Table 103. Takara Bio Business Overview
Table 104. Takara Bio Product
Table 105. Takara Bio Revenue in Exosomes Business (2015-2020) (Million US$)
Table 106. Takara Bio Recent Development
Table 107. Malvern Instruments Company Details
Table 108. Malvern Instruments Business Overview
Table 109. Malvern Instruments Product
Table 110. Malvern Instruments Revenue in Exosomes Business (2015-2020) (Million US$)
Table 111. Malvern Instruments Recent Development
Table 112. Miltenyi Biotec Business Overview
Table 113. Miltenyi Biotec Product
Table 114. Miltenyi Biotec Company Details
Table 115. Miltenyi Biotec Revenue in Exosomes Business (2015-2020) (Million US$)
Table 116. Miltenyi Biotec Recent Development
Table 117. MBL International Company Details
Table 118. MBL International Business Overview
Table 119. MBL International Product
Table 120. MBL International Revenue in Exosomes Business (2015-2020) (Million US$)
Table 121. MBL International Recent Development
Table 122. Lonza Company Details
Table 123. Lonza Business Overview
Table 124. Lonza Product
Table 125. Lonza Revenue in Exosomes Business (2015-2020) (Million US$)
Table 126. Lonza Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosomes Market Share by Type: 2020 VS 2026
Figure 2. Non-coding RNAs Features
Figure 3. Lipids Features
Figure 4. mRNA Features
Figure 5. DNA fragments Features
Figure 6. Proteins /peptides Features
Figure 7. Global Exosomes Market Share by Application: 2020 VS 2026
Figure 8. Cancer Case Studies
Figure 9. Infectious diseases Case Studies
Figure 10. Neurodegenerative diseases Case Studies
Figure 11. Cardiovascular diseases Case Studies
Figure 12. Exosomes Report Years Considered
Figure 13. Global Exosomes Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Exosomes Market Share by Regions: 2020 VS 2026
Figure 15. Global Exosomes Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Exosomes Market Share by Players in 2019
Figure 18. Global Top Exosomes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosomes as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Exosomes Revenue in 2019
Figure 20. North America Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Exosomes Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
POC感染性疾患の世界市場（～2026年） POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies, which has helped the market to grow during the previous forecasted peri…- 感染症の世界市場（～2026年） When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antip…
- 希少疾患の世界市場（～2026年） An orphan disease is defined as a condition that affects fewer than 200,000 people nationwide. This includes diseases as familiar as cystic fibrosis, Lou Gehrig's disease, and Tourette's syndrome, and as unfamiliar as Hamburger disease, Job syndrome, and acromegaly, or "gigantism." Some diseases hav…
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…